The Motley Fool

Key Data Points

Primary metrics and data points about Neurocrine Biosciences, Inc..
Current Price: $43.86
Prev Close: $38.93
Open: $46.25
Bid: $42.82
Ask: $42.93
Day's Range: $41.50 - $47.25
52wk Range: $15.21 - $56.97
Volume: 3,369,671
Avg Vol 1,165,410
Market Cap: $4B
P/E (ttm): -51.22
EPS (ttm): ($0.76)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Neurocrine Biosciences, Inc. from

Business Summary

Industry, sector and description for Neurocrine Biosciences, Inc..

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

NBIX vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Neurocrine Biosciences, Inc..
CAPS Rating 3 out of 5
320 Outperform
49 Underperform
CAPS All Stars
96 Outperform
6 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kevin C. Gorman, CEO

65% Approve

Based on 2 Ratings

Powered by

More Details about Neurocrine Biosciences, Inc.

Primary metrics and data points about Neurocrine Biosciences, Inc..

Company Photos

Powered by Working at